Insiders · Profile

FONTEYNE PAUL R.

Director at Amylyx Pharmaceuticals. Filing since 6 Jan 2022. CIK 0001727550

Company

Date

Role

Action

Shares

Amount

Of holding

AMLX Amylyx Pharmaceuticals, Inc.

6 Jan 2022

Director

Bought

3,947

$74.99K

opened

1 decision on file.